Beryl Y. Eve

1.8k total citations
14 papers, 1.5k citations indexed

About

Beryl Y. Eve is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Beryl Y. Eve has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Beryl Y. Eve's work include Cancer, Hypoxia, and Metabolism (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Beryl Y. Eve is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Beryl Y. Eve collaborates with scholars based in United States and Australia. Beryl Y. Eve's co-authors include Colin P. Dinney, Keiji Inoue, Robert Radinsky, Paul Perrotte, Takayuki Matsumoto, Hiroki Kuniyasu, Daniel J. Hicklin, Joel W. Slaton, Sun Jin Kim and Menashe Bar‐Eli and has published in prestigious journals such as The Journal of Urology, Neoplasia and PubMed.

In The Last Decade

Beryl Y. Eve

13 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beryl Y. Eve United States 11 803 679 363 341 315 14 1.5k
Kazuhiro Kami Japan 20 1.0k 1.3× 1.2k 1.7× 320 0.9× 187 0.5× 272 0.9× 34 2.0k
Kirsi Ropponen Finland 20 841 1.0× 923 1.4× 491 1.4× 188 0.6× 248 0.8× 25 1.9k
Hiroki Hashida Japan 16 1.0k 1.3× 768 1.1× 359 1.0× 181 0.5× 404 1.3× 58 1.8k
Nathalie A. Lokker United States 20 468 0.6× 1.1k 1.6× 247 0.7× 164 0.5× 293 0.9× 29 2.1k
Kuniaki Aridome Japan 21 748 0.9× 504 0.7× 162 0.4× 368 1.1× 572 1.8× 38 1.7k
Cunha Gr United States 6 778 1.0× 683 1.0× 378 1.0× 354 1.0× 185 0.6× 10 1.5k
Naoki Ikenaga Japan 25 962 1.2× 830 1.2× 502 1.4× 285 0.8× 339 1.1× 75 2.3k
Matthew T. Harbison United States 8 924 1.2× 853 1.3× 362 1.0× 275 0.8× 136 0.4× 8 1.6k
Rajiv Bassi United States 19 783 1.0× 925 1.4× 280 0.8× 373 1.1× 232 0.7× 26 1.7k
Shunsuke Yanoma Japan 21 503 0.6× 417 0.6× 323 0.9× 174 0.5× 215 0.7× 53 1.2k

Countries citing papers authored by Beryl Y. Eve

Since Specialization
Citations

This map shows the geographic impact of Beryl Y. Eve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beryl Y. Eve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beryl Y. Eve more than expected).

Fields of papers citing papers by Beryl Y. Eve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beryl Y. Eve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beryl Y. Eve. The network helps show where Beryl Y. Eve may publish in the future.

Co-authorship network of co-authors of Beryl Y. Eve

This figure shows the co-authorship network connecting the top 25 collaborators of Beryl Y. Eve. A scholar is included among the top collaborators of Beryl Y. Eve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beryl Y. Eve. Beryl Y. Eve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Adam, Liana, Peter C. Black, Wassim Kassouf, et al.. (2007). Adenoviral Mediated Interferon-α 2b Gene Therapy Suppresses the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Superficial Bladder Cancer. The Journal of Urology. 177(5). 1900–1906. 15 indexed citations
2.
Mohamedali, Khalid A., Daniel Kedar, Paul Sweeney, et al.. (2005). The Vascular-Targeting Fusion Toxin VEGF121/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors. Neoplasia. 7(10). 912–920. 30 indexed citations
3.
Inoue, Keiji, Joel W. Slaton, Beryl Y. Eve, et al.. (2000). Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.. PubMed. 6(5). 2104–19. 308 indexed citations
4.
Inoue, Keiji, Joel W. Slaton, Sun Jin Kim, et al.. (2000). Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.. PubMed. 60(8). 2290–9. 185 indexed citations
5.
6.
7.
Inoue, Keiji, Joel W. Slaton, Paul Perrotte, Beryl Y. Eve, & Colin P. Dinney. (1999). INTERLEUKIN-8 (IL-8) EXPRESSION REGULATES TUMORIGENICITY AND METASTASIS IN HUMAN BLADDER CANCER. The Journal of Urology. 120–120. 17 indexed citations
8.
Inoue, Keiji, Beryl Y. Eve, Joel W. Slaton, et al.. (1999). INTERLEUKIN-8 (IL-8) EXPRESSION REGULATES METASTASIS IN ANDROGEN-INDEPENDENT PROSTATE CANCER. The Journal of Urology. 54–54. 27 indexed citations
9.
Perrotte, Paul, Takayuki Matsumoto, Keiji Inoue, et al.. (1999). Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.. PubMed. 5(2). 257–65. 489 indexed citations
10.
Dinney, Colin P., Diane R. Bielenberg, Paul Perrotte, et al.. (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.. PubMed. 58(4). 808–14. 220 indexed citations
11.
Dinney, Colin P., Craig Parker, Zhongyun Dong, et al.. (1997). Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.. PubMed. 3(2). 161–8. 30 indexed citations
12.
Dinney, Colin P., Simon Tanguay, C D Bucana, Beryl Y. Eve, & Isaiah J. Fidler. (1995). Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice.. PubMed. 15(6). 585–92. 11 indexed citations
13.
Dinney, Colin P., Rakesh K. Singh, Beryl Y. Eve, et al.. (1995). Isolation and Characterization of Metastatic Variants from Human Transitional Cell Carcinoma Passaged by Orthotopic Implantation in Athymic Nude Mice. The Journal of Urology. 1532–1538. 9 indexed citations
14.
Dinney, Colin P., Rakesh K. Singh, Beryl Y. Eve, et al.. (1995). Isolation and Characterization of Metastatic Variants from Human Transitional Cell Carcinoma Passaged by Orthotopic Implantation in Athymic Nude Mice. The Journal of Urology. 154(4). 1532–1538. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Kami Breakdown of academic impact, for papers by Kirsi Ropponen Breakdown of academic impact, for papers by Hiroki Hashida Breakdown of academic impact, for papers by Nathalie A. Lokker Breakdown of academic impact, for papers by Kuniaki Aridome Breakdown of academic impact, for papers by Cunha Gr Breakdown of academic impact, for papers by Naoki Ikenaga Breakdown of academic impact, for papers by Matthew T. Harbison Breakdown of academic impact, for papers by Rajiv Bassi Breakdown of academic impact, for papers by Shunsuke Yanoma
Rankless by CCL
2026